Key result
A one standard deviation increase in the major depressive disorder polygenic risk score was associated with a 9% increased risk of myocardial infarction (OR 1.09), indicating shared genetic liability.
Why the study?
Although the high comorbidity between mental and cardiovascular diseases is widely recognized, the underlying mechanisms are not yet well understood.
Does a family history or high polygenic risk score for severe mental illness increase the risk of cardiovascular diseases?
Cohort (n=4,513,509)
Does a family history or high polygenic risk score for severe mental illness increase the risk of cardiovascular diseases?
Answers are grounded in this paper and cite their sources.
There is significant familial coaggregation and shared polygenic liability between severe mental disorders (especially MDD) and cardiovascular diseases, highlighting the potential value of integrated family-based screening.
BACKGROUND: The high comorbidity between mental and cardiovascular diseases is widely recognized, but the underlying mechanisms are not yet well understood. We investigated the familial coaggregation and shared genetic loading between these diseases. METHODS: Using claims data from Taiwan's universal health insurance program, we identified cohorts of 4,513,509 individuals with parental information and 3,330,181 with full-sibling information born between 1970 and 1999, and followed up until 2020. Genotyping was available for 106,796 unrelated participants from the Taiwan Biobank. Multiple logistic regression models were used to estimate the association of parental history, full-sibling history, and polygenic risk scores (PRSs) for severe mental illnesses (schizophrenia, bipolar disorder, major depressive disorder [MDD]) with the risk of myocardial infarction, stroke, peripheral arterial disease (PAD), and heart failure. RESULTS: Individuals with a parental history of schizophrenia, bipolar disorder, or MDD were more likely to have stroke and PAD. Coaggregation in full-siblings was observed for MDD with myocardial infarction and heart failure, bipolar disorders with stroke, and schizophrenia with PAD. The PAD risk increased with more relatives affected by MDD; the magnitude of association was larger when both parents were affected than when either parent was affected, and when there were two affected siblings than in those with only one. MDD PRS was positively associated with the risk of myocardial infarction and PAD. CONCLUSIONS: This study revealed familial coaggregation between mental and cardiovascular diseases, and shared polygenic liability of MDD with cardiovascular diseases. Our findings suggest the potential benefit of family-based integrated screening and preventive strategies.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a cohort in Mental disorders and cardiovascular diseases (n=4,513,509). Polygenic risk score (PRS) for major depressive disorder (MDD) vs. Lower polygenic risk score was evaluated on Myocardial infarction associated with per standard deviation increase in MDD polygenic risk score (OR 1.09, 95% CI 1.01-1.19). A one standard deviation increase in the major depressive disorder polygenic risk score was associated with a 9% increased risk of myocardial infarction (OR 1.09), indicating shared genetic liability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: